Screening

Your Organisational Guidance

ebpracticenet urges you to prioritise the following organisational guidance:

MaagklachtenPublished by: NHGLast published: 2025

Patients infected with Helicobacter pylori have a two- to sixfold increased risk of developing gastric cancer and mucosal associated-lymphoid-type lymphoma compared with their uninfected counterparts.[22]​ One large retrospective cohort study from the US found that the risk of gastric cancer was especially higher among racial and ethnic minorities and smokers who were infected with H pylori.[58]​ One systematic review and meta-analysis found that screening for H pylori in an asymptomatic, healthy Asian population followed by H pylori eradication in affected patients reduced the prevalence of gastric cancer.[59]​ However, generalised H pylori screening and eradication for the primary prevention of gastric cancer is not currently recommended for the US population. Focused testing and treatment of H pylori infection is appropriate in high-risk populations for primary and secondary prevention.[3]

Use of this content is subject to our disclaimer